← Eichor
Study identifier: NCT07442552 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Perioperative Sepsis. An Epigenetic Perspective

Condition: Sepsis Abdominal  ·  Sponsor: Carol Davila University of Medicine and Pharmacy

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This single-center, prospective, observational study evaluates the impact of perioperative sepsis on inflammatory response, coagulation abnormalities, cardiac dysfunction, and microRNA expression in adult patients undergoing major abdominal surgery. Forty patients are enrolled and classified into septic and non-septic groups according to international sepsis definitions based on SOFA score criteria. Clinical, biochemical, echocardiographic, and molecular parameters, including selected microRNAs, are assessed preoperatively and within the first 24 hours postoperatively. The study aims to characterize pathophysiological differences associated with perioperative sepsis and to explore the potential prognostic value of microRNAs as early biomarkers of postoperative sepsis.

This description comes directly from the study's public registry record.

Talk to the study team

Sebastian I Isac, Assist. Prof.  ·  0040744543736  ·  sebastian.isac@umfcd.ro

Buzatu Cristina  ·  0040727391477  ·  cristina.buzatu944@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Institutul Clinic FundeniBucharest, Sector 2, RomaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07442552